A study of Native Americans who experienced ischemic stroke showed they carried a high burden of risk factors, nearly all of which grew in prevalence from 2000 to 2016.

A projected increase in extreme weather driven by climate change could have a lasting effect on expectant mothers and their children, according to a study that recently linked maternal heat exposure to an elevated risk of congenital heart defects (CHDs) in the U.S.

Direct oral anticoagulants (DOACs) are on their way to surpassing warfarin as the anticoagulant of choice among Medicaid beneficiaries, despite their higher cost, according to new research published in the Journal of the American College of Cardiology.

Cancer patients who experienced tachycardia within one year of being diagnosed carried higher mortality rates up to a decade later—even after adjusting for clinical characteristics and medication use—according to research presented Jan. 25 at the Advancing the Cardiovascular Care of the Oncology Patient conference.

Breast cancer patients under 60 years old are nearly twice as likely as their healthy counterparts to develop both short- and long-term atrial fibrillation (AF), researchers reported Jan. 29 in Heart Rhythm.

It isn’t too late to sustain a 50-year-long reduction in cardiovascular disease-related deaths, according to research published in Clinical Cardiology—but with rising rates of obesity and diabetes, we’re closer than ever to reversing that progress.

A new analysis published in the Journal of the American College of Cardiology suggests the learning curve for achieving the best transcatheter aortic valve replacement (TAVR) outcomes may have dissipated with a current-generation, balloon-expandable device.

The blood sugar drug dapagliflozin was declared noninferior to placebo in the recent DECLARE-TIMI 58 trial, and while the medication failed to lower rates of major adverse cardiovascular events (MACE) in subjects, it did reduce rates of CV-related death and hospitalizations for heart failure.

Knowing he needed a new heart, Robert Montgomery, MD, saw an opportunity to practice what he preaches. So, the 58-year-old director of NYU Langone Health’s Transplant Institute accepted an organ from a heroin user who died of a drug overdose and had hepatitis C.

CARLSBAD, Calif., Jan. 28, 2019 — Acutus Medical today announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac imaging and mapping visualization system in persistent atrial fibrillation (AF) ablation procedures.